Pharm prime vendor fleet
Ended Awarded Last action
- Contract number
- SPE2DU26F0Q55
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,564
Award facts
- Contract value 100% obligated
- $3,564.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,564.27 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 13, 2026, falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling and extends through December 31, 2036. The contract authorizes firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Department of Defense healthcare operations worldwide.
DMS Pharmaceutical Group, registered in the System for Award Management since July 2001, has demonstrated substantial federal contracting capability through numerous prior delivery orders issued by the Defense Logistics Agency. The company maintains no identified subcontractor relationships and competes effectively in unrestricted federal procurement, with prior awards ranging from under $100 to over $115,000. This delivery order represents one of many issued under the broader PPV-G GEN V acquisition strategy, a $30.3 billion multi-vendor initiative designed to ensure consistent pharmaceutical supply to military healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DU26F0Q55?
SPE2DU26F0Q55 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DU26F0Q55 worth?
The government has obligated $3,564 on SPE2DU26F0Q55.
Is contract SPE2DU26F0Q55 an order under another contract?
Yes. SPE2DU26F0Q55 is a delivery order under SPE2DU25D9815, an indefinite delivery contract.
Was contract SPE2DU26F0Q55 competed?
The extent of competition for SPE2DU26F0Q55 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award